Category Archives


GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease

  • February 22, 2019
  • admin

—The Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) Supports Novel Projects Aimed at Improving Access to High-Quality... Continue Reading

Dr. Doris Wethers Blazed a Trail for Newborn Testing for Sickle Cell Disease

  • February 16, 2019
  • admin

Sickle Cell Disease Association of America, Inc. (SCDAA) celebrates the life and work of Dr. Doris L. Wethers who died at... Continue Reading

Emmaus Life Sciences Launches Its Commercial Co-Payment Assistance Program for Endari™

  • January 28, 2019
  • admin

TORRANCE, Calif., Jan. 28, 2019 /PRNewswire/ — Emmaus Life Sciences, Inc. (Emmaus), a leader in sickle cell disease treatment, announced today that... Continue Reading

CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease

  • January 4, 2019
  • admin

CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation... Continue Reading